McDermott + Bull has successfully placed Joshua (Josh) Woolley as Vice President of Clinical Affairs and Regulatory at Aria CV. Josh will be responsible for launching the company’s early feasibility study and leading ongoing engagements with the FDA to drive product...
McDermott + Bull has successfully placed David O’Toole as Chief Financial Officer at AVITA Medical (NASDAQ: RCEL, ASX: AVH). David will report to and work closely with the CEO, serving as a valued member of the executive leadership team. In this role, he will provide...
McDermott + Bull has successfully placed Virginia Materese as Chief Executive Officer at private equity-backed Aligned Modern Health. Virginia will work closely with the private equity firm Harbour Point Capital to enhance the company’s platform, drive scalability,...
A CONVERSATION WITH RENOWNED VASCULAR SURGEON, DR. FRANK J. VEITH As one of America’s most celebrated surgeons, Dr. Frank Veith’s career was anything but conventional – he’s worked undercover for the CIA, attempted to make Vascular Surgery an independent specialty,...
MEDTECH + LIFE SCIENCES OUTLOOK IN 2023 2022 was an interesting year, to say the least. It was the tale of two markets. After the extremely volatile years of 2020 and 2021, no one could have predicted the sheer amount of momentum that lay ahead in 2022. The economy...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
